First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.15 USD -4.21% Market Closed
Updated: Apr 20, 2024
Section:
 

Wall Street
Price Targets

SNOA Price Targets Summary
Sonoma Pharmaceuticals Inc

There are no price targets for SNOA.
SNOA Lowest Forecast
Wall Street Target
Not Available
SNOA Average Forecast
Wall Street Target
Not Available
SNOA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sonoma Pharmaceuticals Inc Competitors:
Price Targets
603590
Beijing Konruns Pharmaceutical Co Ltd
56% Upside
460
Sihuan Pharmaceutical Holdings Group Ltd
435% Upside
4502
Takeda Pharmaceutical Co Ltd
21% Upside
ELAN
Elanco Animal Health Inc
40% Upside
603590
Beijing Konruns Pharmaceutical Co Ltd
56% Upside
460
Sihuan Pharmaceutical Holdings Group Ltd
435% Upside
4502
Takeda Pharmaceutical Co Ltd
21% Upside
ELAN
Elanco Animal Health Inc
40% Upside
S
005500
Samjin Pharmaceutical Co Ltd
62% Upside
CORT
Corcept Therapeutics Inc
90% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
313% Upside
LYRA
Lyra Therapeutics Inc
136% Upside

Revenue
Forecast

Revenue Estimate
Sonoma Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Sonoma Pharmaceuticals Inc's revenue is -1%. The projected CAGR for the next 3 years is 19%.

-1%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sonoma Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sonoma Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-97%
Average Miss
What are analyst estimates?

See Also

Summary
SNOA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SNOA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SNOA stock valuation using valuation multiples.
Wall Street Estimates
SNOA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SNOA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNOA's stock price target?
Not Available

SNOA doesn't have any price targets made by Wall Street professionals.

What is Sonoma Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Sonoma Pharmaceuticals Inc's revenue is -1%. The projected CAGR for the next 3 years is 19%.

ALPHA SPREAD
Join more than 129,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.